Skip to main content
. 2025;79(3):205–210. doi: 10.5455/medarh.2025.79.205-210

Table 2. Nefopam versus placebo. Abbreviations: SEM: standard error; VAS: visual analogue scale.

Variables Number (percentage) or mean ± SEM
Nefopam
(n = 24)
Placebo
(n = 25)
P-value
Sex
Male 11 (45.8) 15 (60.0) NS
Female 13 (54.2) 10 (40.0)
Age (years) 43.3 ± 3.5 37.7 ± 2.9 NS
Patients weight (Kg) 75.8 ± 1.9 81.4 ± 2.9 NS
Type of operation
Arthroscopic knee operation 6 (25.0) 10 (40.0) NS
Open knee operation 3 (12.5) 4 (16.0)
Trauma operations 6 (25.0) 6 (24.0)
Small joints operations 8 (33.3) 3 (12.0)
Tumor operations 1 (4.2) 2 (66.7)
American society of anesthesia score
One 10 (41.6) 11 (44.0) NS
Two 13 (54.2) 13 (52.0)
Three 1 (4.2) 1 (4.0)
Intraoperative parameters
Torniquet time (minutes) 75.1 ± 5.4 80.4 ± 5.6 NS
Intraoperative opioids use (oral morphine equivalent, mg/day) 54.0 ± 2.1 64.9 ± 2.0 0.001
Postoperative outcome scores
Postoperative opioids use (oral morphine equivalent, mg/day) 0.6 ± 0.4 11.8 ± 1.4 0.0001
Postoperative sedation score (RASS) 0.0 0.0 -
Postoperative torniquet pain score (VAS) 0.04 ± 0.002 1.0 ± 0.5 NS
Postoperative surgical site pain score (VAS) 1.6 ± 0.3 6.7 ± 0.6 0.001